CareDx To Participate in Upcoming Jefferies Healthcare Conference

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)-- CareDx, Inc. (Nasdaq: CDNA) – The Transplant Company™ focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers – today announced that the Company will participate in the Jefferies Healthcare Conference on June 9th, 2022.

CareDx’s management is scheduled to present at the Jefferies Healthcare Conference on Thursday, June 9th, 2022, at 2:00 PM ET. To listen to the webcast, please visit the investor relations section of CareDx’s website at: investors.caredxinc.com.

About CareDx – The Transplant Company

CareDx, Inc., headquartered in South San Francisco, California, is a leading precision medicine solutions company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers. CareDx offers testing services, products, and digital healthcare solutions along the pre- and post-transplant patient journey and is the leading provider of genomics-based information for transplant patients. For more information, please visit: www.CareDx.com.

View source version on businesswire.com: https://www.businesswire.com/news/home/20220602005866/en/

CareDx, Inc.
Sasha King
Chief Marketing Officer
415-287-2393
[email protected]

Investor Relations
Ian Cooney
415-722-4563
[email protected]

Source: CareDx, Inc.

You May Also Be Interested In

• Klarna has received a favorable ruling in PriceRunner litigation, awarding damages of $1.97 billion
• CareDx completes $171.2M sale of lab products unit to Eurobio Scientific
• Unique Sports Group and One Team Football Join Forces to Launch Unique France